Clinical Trials Logo

Pleuropneumonia clinical trials

View clinical trials related to Pleuropneumonia.

Filter by:

NCT ID: NCT03613636 Completed - Diagnosis Clinical Trials

Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)

myCAP
Start date: May 1, 2016
Phase:
Study type: Observational

To investigate the Mycoplasma pneumoniae-specific circulating antibody-secreting cell (ASC) response and Mycoplasma pneumoniae-specific interferon (INF)-γ-secreting T cell response, along with polymerase chain reaction (PCR) and serology, in a cohort of children with community-acquired pneumonia (CAP) and controls.

NCT ID: NCT03568695 Completed - Clinical trials for Chlamydia Trachomatis Infection

Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples

ISTPOOL
Start date: June 29, 2018
Phase: N/A
Study type: Interventional

This study aims to compare the sensitivity of detecting Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium by real-time multiplex PCR in a pooled analysis (i.e. gathering pharyngeal, anorectal and urinary samples) versus the standard of care (where a real-time multiplex PCR is made in each of the three samples).

NCT ID: NCT03530319 Recruiting - Clinical trials for Pneumonia, Mycoplasma

Treatment of Macrolide-resistant Mycoplasma Pneumoniae

Start date: November 10, 2018
Phase: N/A
Study type: Interventional

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

NCT ID: NCT03527992 Recruiting - Pneumonia Clinical Trials

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

OPPAÎ
Start date: March 9, 2018
Phase: N/A
Study type: Interventional

Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.

NCT ID: NCT02618057 Recruiting - Clinical trials for Mycoplasma Pneumoniae Pneumonia

Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia

Start date: June 2016
Phase: Phase 4
Study type: Interventional

Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children.

NCT ID: NCT02511262 Completed - Clinical trials for Mycoplasma Pneumoniae

Detection of Mycoplasma Pneumoniae

Start date: August 2015
Phase: N/A
Study type: Observational

The objective of this Clinical Trial is to define the methods to be used to document that illumigene® Mycoplasma Direct meets its intended use claims, using the illumipro instrument, with throat swab samples collected from symptomatic patients.

NCT ID: NCT02303587 Completed - Clinical trials for Mycoplasma Pneumoniae Pneumonia

Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)

Start date: December 2014
Phase: N/A
Study type: Interventional

The study is designed to investigate difference in percentage of presentation of atelectasis, bronchiectasis, bronchiolitis obliterans, or consolidation in 6 months after discharge in those treated with a low dose regimen of methylprednisolone initiated with 2 or 4 mg/kg/d for 3 days followed by tapering, combined with sequential treatment with azithromycin versus a high dose regimen of methylprednisolone initiated with 10 mg/kg/d for 3 days followed by tapering, combined with sequential treatment with azithromycin.

NCT ID: NCT01661985 Recruiting - Clinical trials for Chlamydia Trachomatis

Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced

Start date: February 2010
Phase: Phase 4
Study type: Interventional

The purpose of this on-going study is to study the number of days after antibiotic treatment has commenced (due to infection caused by the sexually transmitted bacteria Chlamydia trachomatis (CT) and Mycoplasma genitalium(Mg)) it takes to be cured i.e to get a negative test result. The specimens are analyzed on first-catch-urine (men) or patient's self-obtained vaginal sample with quantitive nucleic acid amplification test(NAAT). A secondary aim is to detect macrolide resistant Mg-strains and study whether there are any emerging macrolide resistant Mg-strains after treatment with azithromycin. A third aim is to study whether the participating subjects are adherent to the study protocol meaning 12 samples taken during a period of four weeks.

NCT ID: NCT01586299 Recruiting - Pleuro-pneumonia Clinical Trials

NSAIDs Treatment in Children With Pleuropneumonia

Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the influence of routine NSAIDs treatment for hospitalized children with pleuropneumonia in comparison with acetominophen treatment (all in conjunction with adequate antibiotic therapy).

NCT ID: NCT01555047 Active, not recruiting - Mycoplasma Clinical Trials

Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner

Start date: September 2011
Phase: Phase 4
Study type: Interventional

Genital ureaplasmas (Ureaplasma urealyticum and Ureaplasma parvum) and genital mycoplasmas (Mycoplasma hominis and Mycoplasma genitalium) are natural inhabitants of the male urethra contaminating the semen during ejaculation. However, these microorganisms, especially Ureaplasma urealyticum (Uu) and Mycoplasma hominis (Mh), are potentially pathogenic species playing an etiologic role in both genital infections and male infertility. Despite there are many consentaneous opinions about its relationship with infertility, its correlation with sperm regular parameters is still controversially. Sperm DNA damage can negatively influence fertilization rate, embryo cleavage rate, implantation rate, pregnancy and live birth rate, and is a novel indicator for intrauterine insemination (IUI) pregnancy rate and IVF or ICSI pregnancy loss rate. Until now, there were fewer clinical researches about the relationship among Uu and/or Mh infection, sperm DNA damage, and the IUI pregnancy rate. Thus, the investigators conduct this prospective study to investigate the relationship among them.